Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques LeLorier

Showing results (21-30 of 97) with videos related to

Pageof 10
Sort By:
JACC. Cardiovascular Interventions|June 23, 2012
What determines propensity score depends on what we are determining propensity for: comment on a recent analysis of arterial access route in acute myocardial infarctionBrian J Potter, Samer Mansour, Jacques Lelorier
Molecular Diagnosis & Therapy|September 16, 2018
Value of a Hypothetical Pharmacogenomic Test for the Diagnosis of Statin-Induced Myopathy in Patients at High Cardiovascular RiskDominic Mitchell, Jason R Guertin, Jacques LeLorier
Pharmacoepidemiology and Drug Safety|September 24, 2004
Effectiveness of amoxicillin, azithromycin, cefprozil and clarithromycin in the treatment of acute otitis media in children: a population-based studyCaroline Quach, Jean-Paul Collet, Jacques LeLorier
British Journal of Clinical Pharmacology|March 18, 2004
Acute otitis media in children: a retrospective analysis of physician prescribing patternsCaroline Quach, Jean-Paul Collet, Jacques LeLorier
European Journal of Clinical Pharmacology|September 1, 2016
Performance of the high-dimensional propensity score in adjusting for unmeasured confoundersJason R Guertin, Elham Rahme, Jacques LeLorier
European Journal of Cancer (Oxford, England : 1990)|March 29, 2008
The challenge of conducting pharmacoeconomic evaluations in oncology using crossover trials: the example of sunitinib for gastrointestinal stromal tumourIsabelle Chabot, Jacques LeLorier, Martin E Blackstein
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|July 23, 2005
Treatment persistence with leukotriene receptor antagonists and inhaled corticosteroidsMarc Dorais, Lucie Blais, Isabelle Chabot, et al.
Canadian Respiratory Journal|March 11, 2004
Inhaled corticosteroids in COPD: determinants of use and trends in patient persistence with treatmentLucie Blais, Jean Bourbeau, Odile Sheehy, et al.
The American Journal of Medicine|April 1, 2008
Statins and cancer riskIgor Karp, Hassan Behlouli, Jacques Lelorier, et al.
Health Policy (Amsterdam, Netherlands)|April 16, 2003
Impact of a cost sharing drug insurance plan on drug utilization among individuals receiving social assistanceLucie Blais, Julie Couture, Elham Rahme, et al.
Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
JACC. Cardiovascular Interventions|June 23, 2012
What determines propensity score depends on what we are determining propensity for: comment on a recent analysis of arterial access route in acute myocardial infarctionBrian J Potter, Samer Mansour, Jacques Lelorier
Molecular Diagnosis & Therapy|September 16, 2018
Value of a Hypothetical Pharmacogenomic Test for the Diagnosis of Statin-Induced Myopathy in Patients at High Cardiovascular RiskDominic Mitchell, Jason R Guertin, Jacques LeLorier
Pharmacoepidemiology and Drug Safety|September 24, 2004
Effectiveness of amoxicillin, azithromycin, cefprozil and clarithromycin in the treatment of acute otitis media in children: a population-based studyCaroline Quach, Jean-Paul Collet, Jacques LeLorier
British Journal of Clinical Pharmacology|March 18, 2004
Acute otitis media in children: a retrospective analysis of physician prescribing patternsCaroline Quach, Jean-Paul Collet, Jacques LeLorier
European Journal of Clinical Pharmacology|September 1, 2016
Performance of the high-dimensional propensity score in adjusting for unmeasured confoundersJason R Guertin, Elham Rahme, Jacques LeLorier
European Journal of Cancer (Oxford, England : 1990)|March 29, 2008
The challenge of conducting pharmacoeconomic evaluations in oncology using crossover trials: the example of sunitinib for gastrointestinal stromal tumourIsabelle Chabot, Jacques LeLorier, Martin E Blackstein
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|July 23, 2005
Treatment persistence with leukotriene receptor antagonists and inhaled corticosteroidsMarc Dorais, Lucie Blais, Isabelle Chabot, et al.
Canadian Respiratory Journal|March 11, 2004
Inhaled corticosteroids in COPD: determinants of use and trends in patient persistence with treatmentLucie Blais, Jean Bourbeau, Odile Sheehy, et al.
The American Journal of Medicine|April 1, 2008
Statins and cancer riskIgor Karp, Hassan Behlouli, Jacques Lelorier, et al.
Health Policy (Amsterdam, Netherlands)|April 16, 2003
Impact of a cost sharing drug insurance plan on drug utilization among individuals receiving social assistanceLucie Blais, Julie Couture, Elham Rahme, et al.
Pageof 10